HHS Must Release Billion Dollar Coronavirus Vaccine Contracts, Public Citizen Lawsuit Says

The Public Has A Right to Know How Their Money Is Being Spent

By Public Citizen
Global Research, October 17, 2020
Public Citizen 15 October 2020
Region:
Theme: , ,

Public Citizen today filed a lawsuit against the U.S. Department of Health and Human Services (HHS) to compel disclosure of coronavirus vaccine development and manufacturing contracts with major pharmaceutical corporations worth billions of dollars.

The suit, filed in the U.S. District Court for the District of Columbia, challenges HHS’s withholding of records requested by Public Citizen under the Freedom of Information Act (FOIA) related to Operation Warp Speed, the Trump administration’s initiative to accelerate the development of COVID-19 treatments and vaccines.

Operation Warp Speed, which is co-led by HHS, has given more than $10 billion to pharmaceutical corporations. The terms of these contracts remain secret. Public Citizen first requested Operation Warp Speed’s contracts with AstraZeneca, Johnson & Johnson, Moderna, Pfizer and Regeneron, among others, in May 2020. The contracts could shed light on critical questions like:

  • Will pharmaceutical corporations be required to set a reasonable price for their products, or will they be free to profiteer despite the public’s massive investment?
  • Will taxpayer-funded technology be held as corporate secrets, or can the U.S. government share technology with the World Health Organization to advance scientific research, accelerate manufacturing and more quickly end the global pandemic?
  • What rights does the U.S. government maintain in the factories it is helping build?

“The success, failure and terms of Warp Speed projects may determine when and under what conditions people living in the U.S. receive a safe and effective vaccine,” said Peter Maybarduk, director of Public Citizen’s Access to Medicines program. “Taxpayers deserve to know what they are getting in return for their billions of dollars in investments. Health experts should be able to assess whether our government is doing everything possible to end the pandemic.”

Earlier this year, Public Citizen worked with the group Knowledge Ecology International to demand that HHS enforce its disclosure requirements for a pharmaceutical corporation developing a COVID-19 vaccine. At that time, a leader of Operation Warp Speed responded:

“The trust of the American people is vital in the all-of-America response to the ongoing COVID-19 pandemic. In recognizing this important relationship, the leadership of… Operation Warp Speed [is] committed to remaining transparent with the American people.”

The lawsuit is available here.

*

Note to readers: please click the share buttons above or below. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Featured image is from the author
Articles by: Public Citizen

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]